junctional cancer
Showing 1 - 25 of >10,000
Gastric Cancer Trial in ZhengZhou (SHR1210 combined with FOLFOX)
Active, not recruiting
- Gastric Cancer
- SHR1210 combined with FOLFOX
-
ZhengZhou, Henan, ChinaHenan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jan 11, 2022
GastrOesophageal Tumor, Immune Microenvionnment (GOTIM)
Not yet recruiting
- GastroEsophageal Cancer
-
Lyon, FranceCentre Léon Bérard
Dec 1, 2022
Esophageal Cancer, Gastroesophageal Junction Cancer, Anastomotic Leak Trial in Guangzhou (Porcine Fibrin Sealant (PFS), Surgery)
Completed
- Esophageal Cancer
- +2 more
- Porcine Fibrin Sealant (PFS)
- Surgery
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 22, 2021
Esophageal Cancer, Esophageal Tumors Trial in Milano (hybrid PET/MRI)
Recruiting
- Esophageal Cancer
- Esophageal Neoplasms
- hybrid PET/MRI
-
Milano, ItalyDeaprtment of Radiology, IRCCS Ospedale San Raffaele
Jan 24, 2023
Adenocarcinoma of the Oesophagus, Adenocarcinoma of the Oesophago-gastric Junction, Oesophageal Tumours Trial in Worldwide
Completed
- Adenocarcinoma of the Oesophagus
- +4 more
- Epirubicin
- +9 more
-
Blegdamsvej 9, Denmark
- +28 more
Sep 29, 2022
Swedish Esophageal and Cardia Cancer Study
Active, not recruiting
- Oesophageal Cancer
- +3 more
- (no location specified)
Sep 3, 2023
Gastric, Colorectal Adenocarcinoma Trial in Shenyang (tislelizumab)
Not yet recruiting
- Gastric
- Colorectal Adenocarcinoma
-
Shenyang, Liaoning, ChinaLiaoning Cancer Hospital & Institute
Nov 1, 2023
Esophageal Carcinoma Trial in Rochester (mFOLFOX6, Chemoradiation)
Active, not recruiting
- Esophageal Carcinoma
- mFOLFOX6
- Chemoradiation
-
Rochester, New YorkUniversity of Rochester
Aug 17, 2022
Esophageal Carcinoma, Neoadjuvant Chemoradiotherapy, Surgery Trial in Hangzhou (Higher dose (50.4Gy/28F) of neoadjuvant
Recruiting
- Esophageal Carcinoma
- +2 more
- Higher dose (50.4Gy/28F) of neoadjuvant chemoradiation
- Lower dose (41.4Gy/23F) of neoadjuvant chemoradiation
-
Hangzhou, Zhejiang, China
- +1 more
Mar 12, 2022
Esophageal Squamous Cell Carcinoma Trial in Shanghai (Nivolumab, Cisplatin, Paclitaxel)
Recruiting
- Esophageal Squamous Cell Carcinoma
- Nivolumab
- +4 more
-
Shanghai, China180 Fenglin Road
Jun 12, 2022
Hepatocellular Carcinoma, Hepatitis b Virus, Radiotherapy Trial
Not yet recruiting
- Hepatocellular Carcinoma
- +3 more
- (no location specified)
Feb 21, 2023
Esophageal Cancer, Intensity-modulated Radiation Therapy, Concurrent Chemoradiotherapy Trial in Beijing (rhTPO)
Not yet recruiting
- Esophageal Cancer
- +3 more
-
Beijing, Beijing, ChinaDepartment of Radiation Oncology, Cancer Institute and Hospital,
Jul 12, 2023
Epithelial-Mesenchymal Transition Associated Markers in
Recruiting
- Peri-implantitis
-
Karbala, IraqTalib A. Alnajaty
Apr 14, 2023
Gastric Cancer Trial in Shanghai (Oxaliplatin, Teysuno, Transarterial chemoembolization (TACE))
Not yet recruiting
- Gastric Cancer
- Oxaliplatin
- +2 more
-
Shanghai, Shanghai, ChinaZhongShan hospital FuDan university
May 25, 2022
Esophageal Squamous Cell Carcinoma, Esophagectomy, Radiotherapy Trial (Since the data were collected retrospectively, there were
Completed
- Esophageal Squamous Cell Carcinoma
- +3 more
- Since the data were collected retrospectively, there were no interventions
- (no location specified)
Oct 31, 2022
Oesophageal Cancer Trial in Dublin (oesophagectomy)
Recruiting
- Oesophageal Cancer
- oesophagectomy
-
Dublin, IrelandSt James University Hospital Clinical Research Centre
Apr 4, 2022
Esophageal Adenocarcinoma (UICC TNM7), Adenocarcinoma of the Esophagogastric Junction Trial in Germany (5-Fluorouracil,
Active, not recruiting
- Esophageal Adenocarcinoma (UICC TNM7)
- Adenocarcinoma of the Esophagogastric Junction
- 5-Fluorouracil
- +6 more
-
Aachen, Germany
- +29 more
Nov 1, 2022
Metastatic Solid Tumors of Metastatic Disease Trial in United States (Radiation Therapy, Systemic Therapy)
Recruiting
- Metastatic Solid Tumors of Metastatic Disease
- Radiation Therapy
- Systemic Therapy
-
Miami, Florida
- +8 more
Dec 6, 2022
Esophageal Squamous Cell Carcinoma, Head and Neck Squamous Cell Carcinoma Trial in Chengdu (Camrelizumab, Dalpiciclib 100mg,
Recruiting
- Esophageal Squamous Cell Carcinoma
- Head and Neck Squamous Cell Carcinoma
- Camrelizumab
- +2 more
-
Chengdu, Sichuan, ChinaWest China Hospital, Sichuan University
Oct 25, 2023
Esophageal cAncer Screening Trial
Completed
- Esophageal Squamous Cell Carcinoma
- +2 more
- Sponge cytological test
-
Shanghai, Shanghai, ChinaChanghai Hospital
Sep 17, 2022
Junctional Epidermolysis Bullosa, Dystrophic Epidermolysis Bullosa Trial in United States (RGN-137, Placebo)
Terminated
- Junctional Epidermolysis Bullosa
- Dystrophic Epidermolysis Bullosa
- RGN-137
- Placebo
-
Evanston, Illinois
- +4 more
Aug 18, 2022
Esophageal Squamous Cell Carcinoma Stage II, Esophageal Squamous Cell Carcinoma Stage III Trial in Shanghai (Neoadjuvant
Recruiting
- Esophageal Squamous Cell Carcinoma Stage II
- Esophageal Squamous Cell Carcinoma Stage III
- Neoadjuvant Chemoradiotherapy
- +2 more
-
Shanghai, ChinaShanghai Zhongshan Hospital
Jun 26, 2022